Rock Springs Capital LLC is 10% Owner at Inozyme Pharma, Inc. (INZY). They have made 3 open-market trades across 3 companies since 2020, most recently 2021-10-12.
CIK 0001735397
3 open-market purchases totalling $17.6M since 2020, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.